ATE282019T1 - Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte - Google Patents

Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte

Info

Publication number
ATE282019T1
ATE282019T1 AT00990151T AT00990151T ATE282019T1 AT E282019 T1 ATE282019 T1 AT E282019T1 AT 00990151 T AT00990151 T AT 00990151T AT 00990151 T AT00990151 T AT 00990151T AT E282019 T1 ATE282019 T1 AT E282019T1
Authority
AT
Austria
Prior art keywords
analogas
tolterodine
production
products produced
intermediate products
Prior art date
Application number
AT00990151T
Other languages
English (en)
Inventor
Pehr G Andersson
Christian Hedberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of ATE282019T1 publication Critical patent/ATE282019T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/512Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being a free hydroxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00990151T 1999-12-30 2000-12-22 Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte ATE282019T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904850A SE9904850D0 (sv) 1999-12-30 1999-12-30 Novel process and intermediates
PCT/SE2000/002662 WO2001049649A1 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process

Publications (1)

Publication Number Publication Date
ATE282019T1 true ATE282019T1 (de) 2004-11-15

Family

ID=20418365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990151T ATE282019T1 (de) 1999-12-30 2000-12-22 Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte

Country Status (29)

Country Link
US (1) US6310248B2 (de)
EP (2) EP1242361B1 (de)
JP (1) JP2003519207A (de)
KR (1) KR20020062669A (de)
CN (1) CN1209342C (de)
AR (1) AR027138A1 (de)
AT (1) ATE282019T1 (de)
AU (1) AU782796B2 (de)
BR (1) BR0016785A (de)
CA (1) CA2392832A1 (de)
CZ (1) CZ20022255A3 (de)
DE (1) DE60015799T2 (de)
DK (1) DK1242361T3 (de)
EE (1) EE200200325A (de)
ES (1) ES2228658T3 (de)
HU (1) HUP0203816A3 (de)
IL (1) IL150275A0 (de)
MX (1) MXPA02006415A (de)
MY (1) MY118906A (de)
NO (1) NO20023189L (de)
NZ (1) NZ519079A (de)
PE (1) PE20011123A1 (de)
PL (1) PL355947A1 (de)
PT (1) PT1242361E (de)
SE (1) SE9904850D0 (de)
SK (1) SK9392002A3 (de)
TW (1) TWI225476B (de)
WO (1) WO2001049649A1 (de)
ZA (1) ZA200204066B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (de) * 1998-05-12 1999-11-17 Schwarz Pharma Ag 3,3-Diphenylpropylaminderivate
US6703504B2 (en) 2002-02-11 2004-03-09 Clarke Slemon Conformationally constrained compounds as dendrimer cores
WO2003064501A1 (en) * 2002-01-31 2003-08-07 Clarke Slemon Conformationally restricted compounds as dendrimer cores
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
ITMI20031354A1 (it) * 2003-07-02 2005-01-03 Istituto Di Chimica Biomolecolare D El Cnr Sezione Sintesis enantioselettiva di composti enantiomericamente arricchiti.
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
ITMI20040616A1 (it) * 2004-03-30 2004-06-30 Dinamite Dipharma S P A In For Processo per la preparazione di tolterodina e suoi intermedi
EP1629834A1 (de) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Pharmazeutische Zusammensetzung von Tolterodin mit verzögerter Freisetzung
ITMI20041920A1 (it) * 2004-10-11 2005-01-11 Chemi Spa Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
JP4513535B2 (ja) * 2004-12-03 2010-07-28 住友化学株式会社 トルテロジンの製造方法
JP5207518B2 (ja) * 2004-12-24 2013-06-12 レツク・フアーマシユーテイカルズ・デー・デー 3−(2−ヒドロキシ−5−メチルフェニル)−n,n−ジイソプロピル−3−フェニルプロピルアミンの製造プロセス
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
ES2268987B1 (es) 2005-08-05 2008-02-01 Ragactives, S.L. Procedimiento para la obtencion de 3,3-difenilpropilaminas.
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹n,n-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
KR100686351B1 (ko) * 2006-01-12 2007-02-22 주식회사 카이로제닉스 톨테로딘 라세미체의 제조방법
KR101087326B1 (ko) 2006-05-24 2011-11-25 화이자 리미티드 벤조피란-2-올 유도체의 생성 방법
WO2007144097A1 (en) 2006-06-12 2007-12-21 Schwarz Pharma Ag New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
KR100717361B1 (ko) * 2006-08-07 2007-05-11 주식회사 카이로제닉스 톨테로딘 라세미체 및 이의 중간체의 제조방법
WO2009019599A2 (en) 2007-08-08 2009-02-12 Themis Laboratories Private Limited Extended release compositions comprising tolterodine
EP2334378B1 (de) 2008-08-19 2014-04-09 XenoPort, Inc. Fumarsaeuremonomethylester-prodrugs, pharmazeutische zusammensetzungen daraus und anwendungsverfahren
BRPI0922503A2 (pt) 2008-12-24 2018-11-06 Daiichi Sankyo Company, Limited composto, composição farmacêutica, métodos para melhorar o metabolismo ósseo, e para previnir ou tratar osteoporose
CA2748249C (en) 2008-12-24 2013-07-02 Daiichi Sankyo Company, Limited Cyclic amine compounds
KR101275984B1 (ko) * 2010-10-18 2013-06-18 경기대학교 산학협력단 광학활성을 갖는 크로만계 유도체 및 이의 제조방법
DK2639216T3 (en) * 2010-11-09 2018-09-24 Kaneka Corp Halogenated Indones and Methods for Preparation of Optically Active Indanones or Optically Active Indanols Using These
EP2476665A1 (de) 2011-01-17 2012-07-18 Cambrex Profarmaco Milano S.r.l. Verfahren zur Herstellung von N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl-Propylamin und seine Salze aus einem neuartigen Zwischenstoffs
WO2012098044A1 (en) 2011-01-17 2012-07-26 Cambrex Profarmaco Milano S.R.L. Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
SI3135656T1 (sl) 2011-06-20 2019-05-31 H. Lundbeck A/S Devterirani 1-piperazino-3-fenil indani za zdravljenje shizofrenije
CN103159657B (zh) * 2011-12-08 2016-06-29 重庆华邦胜凯制药有限公司 一种定向合成不饱和共轭醇的方法
AR094054A1 (es) * 2012-12-19 2015-07-08 H Lundbeck As 6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma
KR101380982B1 (ko) 2013-04-29 2014-04-10 경기대학교 산학협력단 광학활성을 갖는 크로만-2-올 유도체 및 이의 제조방법
WO2017137955A1 (en) 2016-02-14 2017-08-17 Celestis Pharmaceuticals Pvt. Ltd. Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol
US20210282443A1 (en) * 2016-07-12 2021-09-16 Chromocell Corporation Compounds, compositions, and methods for modulating sweet taste
US11535600B2 (en) 2018-12-03 2022-12-27 H. Lundbeck A/S Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800207D0 (sv) 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
ZA969363B (en) * 1995-11-08 1997-11-18 Smithkline Beecham Corp An improved process for preparing aromatic ring-fused cyclopentane derivatives.
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
EP0957073A1 (de) * 1998-05-12 1999-11-17 Schwarz Pharma Ag 3,3-Diphenylpropylaminderivate

Also Published As

Publication number Publication date
CN1414944A (zh) 2003-04-30
DE60015799D1 (de) 2004-12-16
NZ519079A (en) 2004-02-27
TWI225476B (en) 2004-12-21
DE60015799T2 (de) 2005-12-15
SE9904850D0 (sv) 1999-12-30
BR0016785A (pt) 2002-09-24
SK9392002A3 (en) 2003-01-09
ES2228658T3 (es) 2005-04-16
HK1052000A1 (en) 2003-08-29
MXPA02006415A (es) 2002-11-29
PL355947A1 (en) 2004-05-31
NO20023189L (no) 2002-07-04
CZ20022255A3 (cs) 2002-11-13
HUP0203816A3 (en) 2004-12-28
EP1496045A2 (de) 2005-01-12
EP1242361B1 (de) 2004-11-10
IL150275A0 (en) 2002-12-01
PE20011123A1 (es) 2001-11-09
EE200200325A (et) 2003-08-15
PT1242361E (pt) 2005-01-31
CA2392832A1 (en) 2001-07-12
US6310248B2 (en) 2001-10-30
US20010016669A1 (en) 2001-08-23
CN1209342C (zh) 2005-07-06
MY118906A (en) 2005-02-28
HUP0203816A2 (hu) 2003-03-28
AR027138A1 (es) 2003-03-12
EP1242361A1 (de) 2002-09-25
WO2001049649A1 (en) 2001-07-12
DK1242361T3 (da) 2005-02-14
AU2719001A (en) 2001-07-16
JP2003519207A (ja) 2003-06-17
AU782796B2 (en) 2005-09-01
KR20020062669A (ko) 2002-07-26
ZA200204066B (en) 2003-07-30
NO20023189D0 (no) 2002-07-01
EP1496045A3 (de) 2005-03-30

Similar Documents

Publication Publication Date Title
ATE282019T1 (de) Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte
DE69404765D1 (de) Batteriebehälter, Blech für die Formgebung des Batteriebehälters und Verfahren für die Herstellung des Bleches
DE68925767D1 (de) Katalysatoren für die Herstellung von Ethylenoxid und Verfahren zur deren Herstellung
EP0401844A3 (de) Resorbierbare Formkörper und Verfahren zu ihrer Herstellung
DE60034342D1 (de) Verfahren für die herstellung von lufthaltigen gefrorenen produkten
DE60015600D1 (de) Geöffnete norbornenringpolymere, deren hydrierungsprodukte sowie verfahren zur herstellung beider produkte
DE69820119D1 (de) Gelierte nahrungsmittel sowie verfahren zu deren herstellung
DE69913975D1 (de) Verfahren und vorrichtung für die herstellung von deodorant oder schweisshemmender zusammensetzung
DE69825253D1 (de) Verfahren für die herstellung von 1,1,1,3,3-pentafluorpropen und 2-chlor-pentafluorpropen
DE69533433D1 (de) Verfahren und Mischung zur Herstellung von Polymerprodukten für die Zahnmedizin
DE69434937D1 (de) Verfahren zur Herstellung von Leistungsbauteilen in MOS-Technologie
DE69934234D1 (de) Verfahren zur herstellung von masa-mehle
DE69509432D1 (de) Verfahren zur Herstellung von Produkten aus Titanlegierung
DE69229134D1 (de) Alkalische Proteinase und deren Verfahren zur Herstellung
DE69617637D1 (de) Verfahren zur herstellung von kontaktlinsen und die so hergestellten kontaktlinsen
DE69813312D1 (de) Verfahren zur herstellung von cyclopropylethyn sowie zwischenprodukte zur herstellung von cyclopropylethyn
DE59105631D1 (de) Verfahren zur herstellung von flächen- und im querschnitt ringförmigen extrudaten sowie vorrichtung zur durchführung des verfahrens.
DE69418581D1 (de) Verfahren zur herstellung dünner bleche, geeignet für die anfertigung von dosenteilen
DE69821473D1 (de) Durch biofidobakterium hergestellte sauermilch sowie verfahren zur herstellung derselben
DE60009388D1 (de) Verfahren für die Bereitung eines Katalysators für eine Verwendung bei der Herstellung von Metacrylsäure und Verfahren für die Herstellung von Metacrylsäure
DE69708789D1 (de) Verfahren zur Herstellung von synthetischen Silicaten und deren Verwendung für die Glasherstellung
ATE397591T1 (de) Verfahren zu herstellung von hiv-protease inhibitoren und zwischenprodukten für ihrer herstellungen
DE69101971D1 (de) Anorganische membranen und verfahren für die herstellung von anorganischen membranen.
ATE213494T1 (de) Verfahren und zwischenprodukte, die für die herstellung von antifolaten verwendbar sind
DE69402484D1 (de) Verfahren zur Herstellung von Naphthochinonen sowie Zwischenprodukte bei deren Herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1242361

Country of ref document: EP

REN Ceased due to non-payment of the annual fee